The New Indian Journal of OBGYN. 12(1):13-17

Intramuscular administration of injection depot medroxy progesterone acetate on day 1 of medical method of abortion

Sonali S Deshpande, Shrinivas Gadappa, Swati Badgire, Apurva Somshekhar Sholapure

ABSTRACT

Background: Medical method abortion (MMA) plays a crucial role in providing access to safe, effective and acceptable abortion care. The most effective way to reduce abortion rates is to prevent unintended pregnancy by improving access to consistent, effective, and affordable contraception. Injection DMPA (Depot medroxy progesterone acetate) is one such synthetic progesterone suitable to fulfil this criterion because they are effective, safe, and reversible with fewer side effects. Objectives: Present study was carried out to study the success rate of medical method of abortion along with injection depot medroxy progesterone acetate (DMPA) administration on day 1 of medical method of abortion. Materials and methods: Present prospective observational study conducted in the department of Obstetrics & Gynaecology in tertiary care hospital during October 2019 – September 2021. Participants were followed up for five visits after enrollment and were contacted at day 1, day 3 and 3 months & 6 months. Results: In present study 55 women were included. Majority of women 32(58.18%) belonged to the age group of 26-30 years. Maximum women 29 (52.73%) had gestational age >7-9 weeks. 46 (86.27%) women were having gravidity between G2-G4. The success rate of MMA along with administration of injection DMPA on the same day was 94.55%. The continuation rate of inj. DMPA (IM) was 90.91%. 4(7.27%) had discontinued inj. DMPA (IM) due to its side effect (amenorrhea). The success rate of injection DMPA as a contraception was 100%. Conclusion: It was concluded that initiation of contraception (Inj. DMPA) on initial visit for medical abortion resulted in high continuation rate without affecting the success of medical abortion.